LATEST NEWS
- Results revealed from phase I clinical trial of the first drug to successfully inhibit the MYC gene, which drives many common cancers
- Omomyc as the first MYC-targeted theraphy to succesfully complete a phase I clinical trial
- TODAY in El Mundo: “Así avanza el fármaco español pionero en su estrategia contra el cáncer”
- TODAY in La Vanguardia: “Èxit del primer assaig en pacients del fàrmac Omomyc contra el càncer”